Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jukka Westerbacka

Showing results (51-60 of 58) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 58 results.
Diabetes, Obesity & Metabolism|February 16, 2019
The Diabetes Unmet Need with Basal Insulin Evaluation (DUNE) study in type 2 diabetes: Achieving HbA1c targets with basal insulin in a real-world settingLuigi F Meneghini, Didac Mauricio, Emanuela Orsi, et al.
European Journal of Endocrinology|September 12, 2009
Role of insulin as a negative regulator of plasma endocannabinoid levels in obese and nonobese subjectsVincenzo Di Marzo, An Verrijken, Antti Hakkarainen, et al.
Journal of the American College of Cardiology|December 20, 2008
Long-term effects of fenofibrate on carotid intima-media thickness and augmentation index in subjects with type 2 diabetes mellitusAnne Hiukka, Jukka Westerbacka, Eeva S Leinonen, et al.
European Journal of Endocrinology|February 12, 2009
Genetic variation in the ADIPOR2 gene is associated with liver fat content and its surrogate markers in three independent cohortsAnna Kotronen, Hannele Yki-Järvinen, Anna Aminoff, et al.
Diabetes|July 11, 2007
Adipose tissue inflammation and increased ceramide content characterize subjects with high liver fat content independent of obesityMaria Kolak, Jukka Westerbacka, Vidya R Velagapudi, et al.
Gastroenterology|July 6, 2010
Splanchnic balance of free fatty acids, endocannabinoids, and lipids in subjects with nonalcoholic fatty liver diseaseJukka Westerbacka, Anna Kotronen, Barbara A Fielding, et al.
Journal of Lipid Research|June 24, 2009
Allele-specific regulation of MTTP expression influences the risk of ischemic heart diseaseAnna Aminoff, Helena Ledmyr, Petra Thulin, et al.
Current Medical Research and Opinion|December 24, 2019
Real-world outcomes of treatment with insulin glargine 300 U/mL versus standard-of-care in people with uncontrolled type 2 diabetes mellitusNick Freemantle, Didac Mauricio, Andrea Giaccari, et al.
Pageof 6

Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
Diabetes, Obesity & Metabolism|February 16, 2019
The Diabetes Unmet Need with Basal Insulin Evaluation (DUNE) study in type 2 diabetes: Achieving HbA1c targets with basal insulin in a real-world settingLuigi F Meneghini, Didac Mauricio, Emanuela Orsi, et al.
European Journal of Endocrinology|September 12, 2009
Role of insulin as a negative regulator of plasma endocannabinoid levels in obese and nonobese subjectsVincenzo Di Marzo, An Verrijken, Antti Hakkarainen, et al.
Journal of the American College of Cardiology|December 20, 2008
Long-term effects of fenofibrate on carotid intima-media thickness and augmentation index in subjects with type 2 diabetes mellitusAnne Hiukka, Jukka Westerbacka, Eeva S Leinonen, et al.
European Journal of Endocrinology|February 12, 2009
Genetic variation in the ADIPOR2 gene is associated with liver fat content and its surrogate markers in three independent cohortsAnna Kotronen, Hannele Yki-Järvinen, Anna Aminoff, et al.
Diabetes|July 11, 2007
Adipose tissue inflammation and increased ceramide content characterize subjects with high liver fat content independent of obesityMaria Kolak, Jukka Westerbacka, Vidya R Velagapudi, et al.
Gastroenterology|July 6, 2010
Splanchnic balance of free fatty acids, endocannabinoids, and lipids in subjects with nonalcoholic fatty liver diseaseJukka Westerbacka, Anna Kotronen, Barbara A Fielding, et al.
Journal of Lipid Research|June 24, 2009
Allele-specific regulation of MTTP expression influences the risk of ischemic heart diseaseAnna Aminoff, Helena Ledmyr, Petra Thulin, et al.
Current Medical Research and Opinion|December 24, 2019
Real-world outcomes of treatment with insulin glargine 300 U/mL versus standard-of-care in people with uncontrolled type 2 diabetes mellitusNick Freemantle, Didac Mauricio, Andrea Giaccari, et al.
Pageof 6